news
Roche’s Perjeta significantly extends survival in people with HER2-positive metastatic breast cancer
8 December 2012 | By Roche
Roche announced updated survival results from the Phase III CLEOPATRA study...
List view / Grid view
Roche
news
Roche and the Innovative Medicines Initiative join forces to promote use of Nobel Prize-winning stem cell technology to enhance drug development
5 December 2012 | By Roche
Roche and the IMI launch StemBANCC...
news
Roche study showed that Avastin helped people with newly diagnosed glioblastoma live longer without their disease worsening
17 November 2012 | By Roche
Results from positive phase III AVAglio study...
news
Roche receives positive opinion from EMA for Avastin based treatment beyond first progression in people with advanced colorectal cancer
16 November 2012 | By Roche
The continued use of Avastin based therapy beyond first progression in metastatic colorectal cancer patients leads to survival benefits...
news
Roche medicine Avastin receives EU approval for the treatment of women with recurrent, platinum-sensitive ovarian cancer
31 October 2012 | By Roche
The EC has approved Avastin...
article
qPCR In-Depth Focus 2012
In this qPCR In-Depth Focus: Setting the bar; Q & A - Mikael Kubista from the TATAA Biocenter poses five questions for Jay Brock, Senior Manager, Applications and Technical Support, USB® Life Science Reagents from Affymetrix; Not your grandfathers’ real-time PCR...
news
FDA clears ACCU-CHEK Inform II
16 October 2012 | By Roche
Hospital point-of-care system for blood glucose testing with improved accuracy and wireless data transfer Next-generation system...
news
Roche’s trastuzumab emtansine (T-DM1) significantly extended survival in people with aggressive form of breast cancer
1 October 2012 | By Roche
Updated survival results from the Phase III EMILIA study...
news
Final analysis of Phase III HERA trial confirmed one year of Herceptin treatment as standard of care in early-stage HER2-positive breast cancer
1 October 2012 | By Roche
Final results from the Phase III HERA trial...
news
Roche underscores leadership in oncology with new data in HER2 positive breast cancer and skin cancer
24 September 2012 | By
Data on 13 of its investigational and approved products will be presented at ESMO 2012...
news
Roche’s Avastin receives positive opinion from CHMP
24 September 2012 | By Roche
For the treatment of women with recurrent, platinum-sensitive ovarian cancer...
news
Ten pharmaceutical companies unite to accelerate development of new medicines
19 September 2012 | By Bristol-Myers Squibb
New non-profit organization to speed pharmaceutical R&D...
news
Roche leads healthcare sector in key sustainability index for fourth consecutive year
13 September 2012 | By Roche
Roche has been recognised as the most sustainable healthcare company...
news
Roche committed to innovation and growth
5 September 2012 | By Roche
Personalised healthcare leadership and world-class pipeline presented at investor conference...
news
Changes to the Roche Corporate Executive Committee
28 August 2012 | By Roche
Daniel O’Day appointed new Head of Roche Pharma– Roland Diggelmann will assume the position Head of Roche Diagnostics...
